TFM
AXSM icon

TFC Financial Management’s Axsome Therapeutics AXSM Stock Holding History

TFC Financial Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245 Hold
1
– – ﹤0.01% 820
2026
Q1 		$170 Hold
1
– – ﹤0.01% 809
2025
Q4 		$183 Hold
1
– – ﹤0.01% 783
2025
Q3 		$122 Hold
1
– – ﹤0.01% 865
2025
Q2 		$105 Buy
+1
New +$106 ﹤0.01% 877

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

TFC Financial Management's AXSM Position: Q2 2026 in Review

TFC Financial Management held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 1 share worth $245. The position accounts for ﹤0.01% of the portfolio, ranked #820.

TFC Financial Management first reported a position in AXSM in Q2 2025 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • TFC Financial Management held 1 share of Axsome Therapeutics worth $245 as of Q2 2026.
  • TFC Financial Management left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #820 holding.
  • TFC Financial Management first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.